PATENT CLAIM ANALYSIS

Application Number: 16148622
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-01
Patent Classification: ["514", "217000"]

Abstract:
Compounds, methods of use, and processes for making inhibitors of complement factor D comprising Formula I, or a pharmaceutically acceptable salt or composition thereof are provided. The inhibitors described herein target factor D and inhibit or regulate the complement cascade at an early and essential point in the alternative complement pathway, and reduce factor D's ability to modulate the classical and lectin complement pathways. The inhibitors of factor D described herein are capable of reducing the excessive activation of complement, which has been linked to certain autoimmune, inflammatory, and neurodegenerative diseases, as well as ischemia-reperfusion injury and cancer.

Claim (Index 15):
The pharmaceutical composition of  claim 9 , wherein the composition comprises at least 100 mg of active compound.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 97.0
- Lexical Diversity: 1.61765
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15676411', '15711794', '15607120', '15700550', '15638076']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8100488971973596
- 35 USC 102 Novelty (BERT): 0.5692873352824084
- Combined Prediction Score: 0.7859727410058645
- Mean Citation Score: 455.323434
- Max Citation Score: 456.14337
- Similarity Product: 359.1697125995475

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test